![Kris Verburgh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Kris Verburgh is the founder of Novos, which was founded in 2020.
He is currently a Venture Partner at Longevity Vision Fund since 2019.
Mr. Verburgh graduated from the University of Antwerp in 2011.
Kris Verburgh active positions
Companies | Position | Start |
---|---|---|
Longevity Vision Fund
![]() Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Private Equity Investor | 2019-02-28 |
Novos
![]() Novos Packaged SoftwareTechnology Services Novos is a public benefit corporation that develops science-based solutions to slow down human aging. The company was founded by Chris Mirabile, Kris Verburgh, and is based in New York, NY. The company is the first supplement targeting aging at the root cause and address 12 hallmarks of aging for optimal longevity and lifespan. Novos offers the first anti-aging supplements in the world based on the best available science to address aging. Chris Mirabile has been the CEO since incorporation. | Founder | 2019-12-31 |
Training of Kris Verburgh
University of Antwerp | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Longevity Vision Fund
![]() Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Finance |
Novos
![]() Novos Packaged SoftwareTechnology Services Novos is a public benefit corporation that develops science-based solutions to slow down human aging. The company was founded by Chris Mirabile, Kris Verburgh, and is based in New York, NY. The company is the first supplement targeting aging at the root cause and address 12 hallmarks of aging for optimal longevity and lifespan. Novos offers the first anti-aging supplements in the world based on the best available science to address aging. Chris Mirabile has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Kris Verburgh